|
ZNF510 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61640000273522E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.00499999988735E-07 |
| Normal-vs-Stage2 |
3.834800E-04 |
| Normal-vs-Stage3 |
2.0285999546843E-09 |
| Normal-vs-Stage4 |
1.47299950015167E-10 |
| Stage1-vs-Stage2 |
2.394000E-01 |
| Stage1-vs-Stage3 |
5.368300E-02 |
| Stage1-vs-Stage4 |
2.902500E-03 |
| Stage2-vs-Stage3 |
1.965860E-02 |
| Stage2-vs-Stage4 |
3.884500E-03 |
| Stage3-vs-Stage4 |
3.032400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.81579995062987E-09 |
| Normal-vs-AfricanAmerican |
2.156000E-04 |
| Normal-vs-Asian |
3.09869999992607E-07 |
| Caucasian-vs-AfricanAmerican |
8.560000E-01 |
| Caucasian-vs-Asian |
9.404000E-01 |
| AfricanAmerican-vs-Asian |
9.101200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09289999775208E-08 |
| Normal-vs-Female |
2.68440000228409E-08 |
| Male-vs-Female |
5.924800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.4152000034976E-08 |
| Normal-vs-Age(41-60Yrs) |
4.15180000379323E-08 |
| Normal-vs-Age(61-80Yrs) |
2.42059999822075E-08 |
| Normal-vs-Age(81-100Yrs) |
1.876060E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.231200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.554800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.030200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.712600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.399000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.514200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.803300E-03 |
| Classical-VS-Follicular |
4.870600E-01 |
| Classical-VS-Other |
4.502600E-01 |
| Classical-VS-Normal |
1.50410000010481E-07 |
| Tall-VS-Follicular |
3.358100E-03 |
| Tall-VS-Other |
5.876400E-01 |
| Tall-VS-Normal |
4.49789983036908E-10 |
| Follicular-VS-Other |
3.947200E-01 |
| Follicular-VS-Normal |
1.66130000001097E-06 |
| Other-VS-Normal |
7.616200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33450003772617E-09 |
| Normal-vs-N1 |
3.19410053961633E-10 |
| N0-vs-N1 |
1.130380E-02 |
|
|
